We are offering our customers a wide range of Reboxetine Mesylates, which are available in various sizes and specifications.\015\012Assay a Y99.0%\015\012CAS:98769-84-7\015\012\015\012Our Reboxetine Mesylates are available at industrial leading price

Technical Specification of Erlotinib HCL :-\015\012Chemical Name : Erlotinib HCL\015\012183319-69-9 \015\012Purity : \342\211\24599.0%\015\012Total impurity : \342\211\2441.0%\015\012Single impurity : \342\211\2440.1%\015\012Erlotinib base : 183321-74-6\015\012\015\012These Erlotinib HCLs are availa

Technical Parameters of Pazopanib HCL :-\015\012Chemical Name : Pazopanib HCL\011\015\012CAS. : 635702-64-6\015\012Purity : \342\211\24599.0%\015\012Total impurity : \342\211\2441.0%\015\012Single impurity : \342\211\2440.3%\015\012\015\012Our Pazopanib HCLs are available at industrial leading price

Technical Parameters of Sorafenib Tosylate :-\015\012Chemical Name : Sorafenib Tosylate\015\012CAS No. 475207-59-1 \015\012Purity : \342\211\24599.0%, \015\012Total impurity \342\211\2441.0%\015\012Single impurity \342\211\2440.3%\015\012Sorafenib base\011284461-73-0\015\012N-Methyl-4-chloropyridine

Lapatinib Ditosylate\011388082-78-8\015\012Lapatinib base\011231277-92-2\015\0124-(3-fluorobenzyloxy)-3-chlorobenzenamine hydrochloride\011202197-26-0\015\012N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-iodoquinazolin-4-amine\011231278-20-9\015\012N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-bromoquin

We are instrumental in trading a qualitative range of Inositol including Reboxetine Mesylate, Erlotinib HCL, Pazopanib HCL etc.

CHICO Pharmaceutical Co., Ltd. - Exporter of Inositol, Reboxetine Mesylate, Lapatinib Ditosylate from Nanjing, Jiangsu, China.

CHICO Pharmaceutical Co., Ltd. - Inositol (5)

All Categories

Reboxetine Mesylate

Erlotinib HCL

Pazopanib HCL

Sorafenib Tosylate - CAS No. 475207-59-1, Purity â¥99.0% | High-Quality Pharmaceutical Grade, Minimal Impurities

Lapatinib Ditosylate - â¥99.0% Purity, Total Impurity â¤1.0%, Single Impurity â¤0.3% | Pharmaceutical Intermediates for Anticancer and Antidiabetic Applications